ClinicalTrials.Veeva

Menu

Immunization Delivery in Obstetrics and Gynecology Settings

University of Colorado Denver (CU Denver) logo

University of Colorado Denver (CU Denver)

Status

Completed

Conditions

Immunization Status Among Obstetrics and Gynecology Patients

Treatments

Behavioral: Multimodal Vaccine Program

Study type

Interventional

Funder types

Other
Other U.S. Federal agency

Identifiers

NCT01565135
11-1149
U01IP000501 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The purpose of this study is to determine if a multimodal immunization program carried out in obstetrics and gynecology (ob/gyn) practices would be more effective in improving ob/gyn patients' immunization rates, specifically for Tdap (Tetanus, Diphtheria, Pertussis), HPV (Human papilloma virus), and influenza vaccines, than the usual care provided to patients in ob/gyn practices.

Enrollment

97,087 patients

Sex

Female

Ages

15+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. 15 years of age or older when presenting for care
  2. Patients who present for care one year prior to the start of the intervention and up to 21 months after the start of the intervention

Exclusion criteria

  1. less than 15 years of age when presenting for care
  2. patient is not eligible for any immunizations

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

97,087 participants in 2 patient groups

Intervention Practices
Experimental group
Description:
Intervention offices will adopt a multimodal vaccine program to increase their patients' vaccine rates.
Treatment:
Behavioral: Multimodal Vaccine Program
Control Practices
No Intervention group
Description:
Control offices will offer usual health care related to immunizations throughout the duration of the study.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems